First report on screening an asymptomatic population for cancer: The yield of an integrated cancer prevention center.

Authors

null

Tal Sella

Sheba Medical Center, Ramat Gan, Israel

Tal Sella , Ben Boursi , Amira Gat-Charlap , Ilan Aroch , Eliezer Liberman , Menachem Moshkowitz , Ehud Miller , Eyal Gur , Arye Blachar , Nicola J. Mabjeesh , Fanny Sperber , Vadim Reiser , Shlomi Kleinman , Ariel J. Jaffa , Mati Ormianer , Inna Naumov , Diana Kazanov , Sarah Kraus , Lior Galazan , Nadir Arber

Organizations

Sheba Medical Center, Ramat Gan, Israel, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Department of Plastic Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Department of Radiology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Department of Oral and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, Department of Obstetrics and Gynecology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Research Funding

No funding sources reported
Background: Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality. We aimed to evaluate the utility of cancer screening in an asymptomatic population at an integrated cancer prevention center. Methods: One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers by routine screening tests. Results: Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the general Israeli population – 78% compared to 60% for mammography (p<0.001) and 39% compared to 16% for colonoscopy (p<0.001). Advanced age, family history and certain lifeclass parameters were associated with increased risk for cancer. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]). Conclusions: A significant number of neoplastic lesions were diagnosed at an early stage. Polymorphisms in the APC and CD24 genes may identify individuals at an increased risk for cancer. Cancer may be diagnosed at an early stage using the screening facilities of a multidisciplinary outpatient clinic.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention/Epidemiology

Track

Cancer Prevention/Epidemiology

Sub Track

Cancer Prevention

Citation

J Clin Oncol 30, 2012 (suppl; abstr 1564)

DOI

10.1200/jco.2012.30.15_suppl.1564

Abstract #

1564

Poster Bd #

4F

Abstract Disclosures

Similar Abstracts

First Author: Vedaamrutha Reddy

Abstract

2024 ASCO Annual Meeting

Cost effectiveness of colorectal cancer screening in the Dominican Republic.

First Author: Yoanna S. Pumpalova

Abstract

2023 ASCO Annual Meeting

Rates of colorectal cancer screening versus lung cancer screening: Where does the problem lie?

First Author: Sasmith R. Menakuru